Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

DOX and CYC dual-drug loaded HA-SS-PLGA particles

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

hyaluronic acid-cystamine-polylactic-co-glycolic acid

HA-SS-PLGA polymer HA-SS-PLGA
Type Polymer
Formula
Role carriers
2

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
3

cyclopamine

CPA CYC CP
Type Single Compound
Formula C27H41NO2
Role loaded material

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Product

DOX and CYC dual-drug loaded HA-SS-PLGA particles

Method 2

Type: Physical formation
Source:
Product

DOX and CYC dual-drug loaded HA-SS-PLGA particles

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • hyaluronic acid-cystamine-polylactic-co-glycolic acid
  • cyclopamine
  1. PQaOH2RDtDkf2wyhcwFMlMd67o
Product

DOX and CYC dual-drug loaded HA-SS-PLGA particles

Method 4

Type: Chemical synthesis
Source:
Starting materials
  • hyaluronic acid-cystamine-polylactic-co-glycolic acid
  • cyclopamine
  1. QpKEB1IqY3WIWzmKt1V84Otypp
Product

DOX and CYC dual-drug loaded HA-SS-PLGA particles

Method 5

Type: Physical formation
Source:
  1. VyjKQkBKQ8J3
Product

DOX and CYC dual-drug loaded HA-SS-PLGA particles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial